Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Pfizer bets on biotech flu vaccine in 425 million dollar BioNTech alliance

      Pfizer bets on biotech flu vaccine in 425 million dollar BioNTech alliance

      Ruby Khatun Khatun17 Aug 2018 9:30 AM IST
      FRANKFURT: Pfizer has agreed to pay German biotech firm BioNTechup to $425 million in an alliance to develop more effective influenza jabs, the latest...
      NPPA fixes maximum retail prices of 92 drugs, details

      NPPA fixes maximum retail prices of 92 drugs, details

      Ruby Khatun Khatun16 Aug 2018 5:52 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Government extends caps price of knee implants for one more year

      Government extends caps price of knee implants for one more year

      Ruby Khatun Khatun16 Aug 2018 4:40 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Fortis shareholders give approval for stake sale to IHH

      Fortis shareholders give approval for stake sale to IHH

      Ruby Khatun Khatun16 Aug 2018 4:38 PM IST
      New Delhi: Fortis Healthcare said its shareholders have given nod to the acquisition of the domestic healthcare chain by Malaysia's IHH Healthcare.The...
      Sun Pharma Q1 net profit at Rs 982 crore

      Sun Pharma Q1 net profit at Rs 982 crore

      Ruby Khatun Khatun16 Aug 2018 10:15 AM IST
      New Delhi: Sun Pharmaceutical Industries reported a consolidated net profit of Rs 982.51 crore for the June quarter of 2018-19.The company had posted...
      Long-acting injection boosts hopes for GSKs HIV business

      Long-acting injection boosts hopes for GSK's HIV business

      Ruby Khatun Khatun16 Aug 2018 10:00 AM IST
      LONDON: A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling...
      Hikma sees higher full-year revenue, shares climb

      Hikma sees higher full-year revenue, shares climb

      Ruby Khatun Khatun16 Aug 2018 9:45 AM IST
      London: London-listed Hikma Pharmaceuticals expects higher full-year revenue after raising forecasts at its top injectables and generics businesses,...
      Australian pharma giant CSL breaks profit record on US sales

      Australian pharma giant CSL breaks profit record on US sales

      Ruby Khatun Khatun16 Aug 2018 9:30 AM IST
      SYDNEY: Australian biotherapeutics company CSL Ltd posted record profit and forecast an even better year in 2018-19 on the back of strong sales in the...
      Cadila Healthcare to acquire Windlass Healthcare for Rs 155.55 crore

      Cadila Healthcare to acquire Windlass Healthcare for Rs 155.55 crore

      Ruby Khatun Khatun15 Aug 2018 10:44 AM IST
      Cadila Healthcare said that Windlas Healthcare has a robust manufacturing infrastructure with USFDA inspected oral solids manufacturing facility.New...
      Glenmark inks pact with private equity firm True North

      Glenmark inks pact with private equity firm True North

      Ruby Khatun Khatun15 Aug 2018 10:30 AM IST
      New Delhi: Glenmark Pharmaceuticals said it has entered into a collaboration with private equity firm True North for its orthopaedic and pain...
      China, Korea overtaking India in vaccine exports: Experts

      China, Korea overtaking India in vaccine exports: Experts

      Ruby Khatun Khatun15 Aug 2018 10:15 AM IST
      HYDERABAD: India, once called as the vaccine capital, is slowly losing its sheen because of various reasons, primarily the aggressive marketing...
      Alnylams gene silencing drug wins FDA approval

      Alnylam's gene silencing drug wins FDA approval

      Ruby Khatun Khatun15 Aug 2018 10:00 AM IST
      Alnylam Pharmaceuticals Inc’s drug for a rare hereditary disease won U.S. regulatory approval, becoming the first approved treatment from a new class...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok